Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Krebs Biochemicals & Industries Ltd. ( (IN:KREBSBIO) ) has shared an update.
Krebs Biochemicals & Industries Ltd. announced that its board of directors has approved the unaudited financial results for the third quarter and nine-month period ended 31 December 2025, fulfilling its disclosure obligations to stock exchanges. The board meeting, held on 9 February 2026, also noted the auditors’ limited review report on these standalone results, confirming that no material misstatements or non-compliance with Indian Accounting Standards and listing requirements were identified.
The completion of this review process signals continued regulatory compliance and financial reporting discipline, providing investors and other stakeholders with interim visibility into the company’s performance. While specific financial figures were not disclosed in the announcement, the clean limited review report supports confidence in the reliability of the disclosed numbers and underscores the company’s adherence to governance norms in the Indian capital markets.
More about Krebs Biochemicals & Industries Ltd.
Krebs Biochemicals & Industries Ltd. operates in the pharmaceutical and biochemicals sector, focusing on the manufacture of bulk drugs and related biochemical products for regulated and domestic markets. The company is listed on both BSE and NSE, reflecting its access to public capital markets and obligations under Indian securities listing regulations.
The company adheres to Indian Accounting Standards and regulatory disclosure requirements, positioning itself as a compliant player within the broader life sciences and specialty chemicals ecosystem. Its governance structure involves regular board oversight of financial reporting, supported by independent auditors conducting limited reviews of interim results.
Average Trading Volume: 3,615
Technical Sentiment Signal: Sell
Current Market Cap: 1.23B INR
Learn more about KREBSBIO stock on TipRanks’ Stock Analysis page.